LPS is a marker of endotoxemia, which promotes skeletal-muscle-insulin resistance by proinflammatory cytokine expression of TNF-α, interleukin-1 (IL-1), interleukin-2 (IL-2), and IL-6 [100,101]. This evidence concerns the gene IL2 and serum lipopolysaccharide activity.